Who Makes Wegovy — and What Does That Mean for You?

Novo Nordisk is a global biopharmaceutical company headquartered in Bagsværd, Denmark. The company has specialised in hormone-based medicines for many decades, most notably insulin for diabetes management, and more recently GLP-1 receptor agonists such as semaglutide.

Wegovy and Ozempic — same substance, different licences

Both Wegovy and Ozempic contain semaglutide, but they are licensed for distinct purposes and supplied in different dose formats. Wegovy is the brand specifically licensed as a weight-management treatment, while Ozempic is licensed primarily for blood-sugar management in type 2 diabetes. Your prescriber or doctor will have prescribed the version appropriate for your situation — the distinction matters clinically, so it is worth being clear about which product you have been given.

For a broader overview of what Wegovy is and how it works, see our guide to Wegovy.

What about Mounjaro — who makes that?

Mounjaro (tirzepatide) is made by a different company entirely: Eli Lilly, a US-based pharmaceutical company. Tirzepatide works as a dual GIP and GLP-1 receptor agonist, which distinguishes it mechanically from semaglutide. If you want to understand the manufacturer behind that medicine, our page on who makes Mounjaro covers it in full.

Why the manufacturer matters

Knowing the manufacturer is useful for practical reasons. If you ever need to report a suspected side effect, your national pharmacovigilance scheme — such as the UK's Yellow Card scheme, or the equivalent body in your country — will record the brand and manufacturer as part of the report. Novo Nordisk also maintains a medical information service if your pharmacist or prescriber needs to escalate a product-specific query. Always direct clinical questions about your own treatment to your prescriber or doctor first; manufacturer resources are typically intended for healthcare professionals rather than patients directly.

Knowing who manufactures Wegovy is a useful piece of context — but staying consistent with your treatment week to week is where the real work happens. GLP Trackr's dose and injection logging lets you record every Wegovy shot: the date, dose strength, and injection site, all in one place. Over time, that log becomes a clear, timestamped record you can bring to your prescriber or doctor, making appointments more productive and giving you confidence that nothing has been missed.

The app also includes dose reminders — a simple way to make sure your weekly schedule stays on track regardless of how busy life gets. And if you ever want to understand how your body is responding across weight, energy, mood, and side effects, the daily check-in and insights features pull it all together into a picture that's genuinely yours.

For a fuller understanding of the medicine itself — including who it is and is not suitable for — it is worth reading about Wegovy and how it works, and if you are curious about suitability questions more broadly, our page on who should not take Mounjaro illustrates the kinds of factors prescribers consider across GLP-1 medicines generally.

You can also explore our Mounjaro hub if you want to compare how both GLP-1 treatment journeys are supported in the app.

Any questions about your specific prescription, dose, or treatment suitability should always go to your prescriber or doctor — GLP Trackr helps you record and reflect on your journey, but it is not a substitute for their guidance.

Ready to build a cleaner record of your Wegovy journey? Download GLP Trackr free on the App Store or Google Play and explore it with a 7-day free trial.